Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...
Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback